Loading the company…
Loading the company…
Families: Peripheral arterial intervention, Coronary intervention (PCI).
All companies · Product and company coverage
In the last ten years FDA made 4 decisions for Kaneka (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2017 (3). The latest was on 2018-03-19.
| Family | Decisions on record |
|---|---|
| Peripheral arterial intervention | 6 |
| Coronary intervention (PCI) | 3 |
| Crosstella OTW |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Kaneka.